Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS Program

AIMS: Sodium glucose co‐transporter 2 (SGLT2) inhibitors reduce several cardiovascular risk factors, including plasma glucose, blood pressure, albuminuria and body weight. Long‐term treatment lowers risks of cardiovascular and renal events. The objective of this post hoc analysis was to determine th...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Diabetes Obes Metab
Hoofdauteurs: Ohkuma, Toshiaki, Van Gaal, Luc, Shaw, Wayne, Mahaffey, Kenneth W., de Zeeuw, Dick, Matthews, David R., Perkovic, Vlado, Neal, Bruce
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Blackwell Publishing Ltd 2020
Onderwerpen:
Original Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7078821/
https://ncbi.nlm.nih.gov/pubmed/31729107
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13920
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items